Remodeling Hearts. Reshaping Lives.
The Coapsys® and iCoapsysTM devices are designed to deliver the only complete, less invasive reshaping therapy for functional mitral regurgitation (FMR) and left ventricular (LV) dysfunction offering short and long term benefits to more patients.
CAUTION: Investigational Device. Limited by US law to investigational use
Devices
The Coapsys device allows for a less invasive, closed heart surgical treatment option for FMR and LV dysfunction. The iCoapsys device offers a closed chest, catheter-based, less invasive interventional treatment option for FMR and LV dysfunction.
New! Clinical Investigators Only
New! VIVID Investigational Sites Only
Clinical Trials
Myocor is sponsoring two Clinical Trials. The RESTOR-MV landmark trial is a prospective, randomized evaluatiion of the safety and efficacy of the Coapsys device compared to annuloplasy repair. The VIVID study is a prospective, non-randomized, single arm feasibility evaluation of the iCoapsys device.